Avantor, Inc. (NYSE:AVTR) Shares Sold by Seelaus Asset Management LLC

Seelaus Asset Management LLC trimmed its position in Avantor, Inc. (NYSE:AVTR) by 11.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 12,215 shares of the company’s stock after selling 1,550 shares during the quarter. Seelaus Asset Management LLC’s holdings in Avantor were worth $316,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of AVTR. Simplify Asset Management Inc. raised its position in Avantor by 67.4% during the 3rd quarter. Simplify Asset Management Inc. now owns 84,678 shares of the company’s stock worth $2,191,000 after buying an additional 34,102 shares during the last quarter. CIBC Asset Management Inc increased its stake in shares of Avantor by 5.6% in the third quarter. CIBC Asset Management Inc now owns 24,165 shares of the company’s stock worth $625,000 after acquiring an additional 1,290 shares during the period. Metis Global Partners LLC raised its holdings in shares of Avantor by 5.1% during the third quarter. Metis Global Partners LLC now owns 26,053 shares of the company’s stock worth $674,000 after purchasing an additional 1,256 shares during the last quarter. Parametrica Management Ltd acquired a new position in Avantor during the third quarter valued at $216,000. Finally, Bancreek Capital Management LP boosted its holdings in Avantor by 21.1% in the third quarter. Bancreek Capital Management LP now owns 721,088 shares of the company’s stock valued at $18,655,000 after purchasing an additional 125,844 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Price Performance

Shares of Avantor stock opened at $20.75 on Friday. The stock has a market capitalization of $14.12 billion, a P/E ratio of 45.11, a PEG ratio of 2.61 and a beta of 1.35. The business has a 50 day simple moving average of $24.52 and a two-hundred day simple moving average of $24.01. Avantor, Inc. has a 12 month low of $19.11 and a 12 month high of $28.00. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on AVTR. Royal Bank of Canada reiterated an “outperform” rating and set a $34.00 price objective on shares of Avantor in a research note on Thursday, September 26th. Barclays lowered their price objective on Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Friday, October 25th. Stifel Nicolaus boosted their target price on shares of Avantor from $27.00 to $28.00 and gave the company a “buy” rating in a research note on Monday, July 29th. UBS Group dropped their price target on shares of Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a research report on Tuesday, October 8th. Finally, Robert W. Baird decreased their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research report on Monday, October 28th. Three equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat, Avantor presently has a consensus rating of “Moderate Buy” and a consensus price target of $27.57.

Insider Activity at Avantor

In related news, CAO Steven W. Eck sold 3,525 shares of the company’s stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $25.06, for a total transaction of $88,336.50. Following the completion of the sale, the chief accounting officer now owns 29,544 shares of the company’s stock, valued at approximately $740,372.64. This represents a 10.66 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.50% of the stock is owned by corporate insiders.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.